Literature DB >> 14744520

The Speech Anxiety Thoughts Inventory: scale development and preliminary psychometric data.

Yongrae Cho1, Jasper A J Smits, Michael J Telch.   

Abstract

Cognitions have been known to play a central role in the development, maintenance, and treatment of speech anxiety. However, few instruments are currently available to assess cognitive contents associated with speech anxiety. This report describes three studies examining the psychometric characteristics of a revised English version of the Speech Anxiety Thoughts Inventory (SATI)-an instrument measuring maladaptive cognitions associated with speech anxiety. In Study 1, factor analyses of the SATI revealed a two-factor solution-"prediction of poor performance" and "fear of negative evaluation by audience", respectively. In Study 2, the two-factor structure was replicated. In addition, results revealed stability over a four-week period, high internal consistency, and good convergent and discriminant validity. In Study 3, the scale demonstrated sensitivity to change following brief exposure-based treatments. These findings suggest that the SATI is a highly reliable, valid measure to assess cognitive features of speech anxiety.

Entities:  

Mesh:

Year:  2004        PMID: 14744520     DOI: 10.1016/s0005-7967(03)00067-6

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  3 in total

1.  Attention guidance augmentation of virtual reality exposure therapy for social anxiety disorder: a pilot randomized controlled trial.

Authors:  Mikael Rubin; Karl Muller; Mary M Hayhoe; Michael J Telch
Journal:  Cogn Behav Ther       Date:  2022-04-06

Review 2.  Rating scales for anxiety/anxiety disorders.

Authors:  Richard Balon
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

3.  Cognitive behaviour language therapy for speech anxiety among stuttering school adolescents.

Authors:  Amuche Nnamani; Josephine Akabogu; Mkpoikanke Sunday Otu; Evelyn Ukoha; Annah C Uloh-Bethels; Jacinta Chinwe Omile; Maureen Nnenna Obiezu; Anastasia E Dike; Chioma Vivian Ike; Olayinka M Iyekekpolor
Journal:  J Int Med Res       Date:  2019-06-03       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.